Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma

This study has been completed.
Sponsor:
Collaborator:
Novartis Pharma AG, Switzerland
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT01393340
First received: July 7, 2011
Last updated: July 11, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)